Helus Pharma Announces Topline Results in Phase 2 Signal Detection Study for HLP004 in Patients with Generalized Anxiety Disorder March 5, 2026 · Financial Post Figure 1 Read MoreVisit chickenroad-game.rodeo for more information. Read full story at source